- Home
- PED vs ICCC Comparison
PED vs ICCC Comparison
Compare PED & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PED | ICCC |
|---|---|---|
| Founded | N/A | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 55.5M |
| IPO Year | 2012 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PED | ICCC |
|---|---|---|
| Price | $0.73 | $6.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 560.8K | 12.1K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.33 |
| EPS | N/A | ★ 0.20 |
| Revenue | ★ $39,553,000.00 | $26,493,169.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $305.89 | N/A |
| P/E Ratio | ★ N/A | $32.15 |
| Revenue Growth | 28.49 | ★ 51.64 |
| 52 Week Low | $0.43 | $4.32 |
| 52 Week High | $0.82 | $7.60 |
Technical Indicators
Market Signals| Indicator | PED | ICCC |
|---|---|---|
| Relative Strength Index (RSI) | 62.98 | 50.04 |
| Support Level | $0.57 | $5.72 |
| Resistance Level | $0.82 | $6.89 |
| Average True Range (ATR) | 0.06 | 0.24 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 60.01 | 43.81 |
Price Performance
Historical ComparisonAbout PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.